Coated Liposome Composition With Cyclodextrin for Skin Penetration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The skin's protective functions hinder the deeper penetration of poorly soluble active ingredients, necessitating improved strategies for topical administration.

Innovation Solution

A composition of coated liposomes containing alkylated or hydroxyalkylated β-cyclodextrin derivatives and modified starch, which enhances the solubility and permeability of poorly soluble active ingredients through the skin.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the skin's protective barrier functions are maintained, then protection against external influences is improved, but penetration of poorly soluble active ingredients deteriorates

Engineering Contradiction:
Improveprotective barrier functionVSAvoidpenetration of active ingredients
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs cyclodextrin derivatives as intermediary carriers that form inclusion complexes with poorly soluble active ingredients, and coated liposomes as mediating delivery systems that transport these complexes across the skin barrier. This intermediary approach allows the skin's protective barrier to remain intact while enabling effective delivery of hydrophobic substances through the cyclodextrin-liposome system.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite delivery system combining cyclodextrin derivatives (which solubilize hydrophobic compounds) with liposomes (which provide membrane-like structures for skin penetration). This composite material approach resolves the contradiction by integrating two different mechanisms: cyclodextrins address solubility while liposomes address permeability, allowing both barrier protection and effective delivery.

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If solubility of poorly soluble active ingredients is improved using cyclodextrin derivatives, then concentration in formulation is improved, but skin permeability may deteriorate

Engineering Contradiction:
Improvesolubility and concentrationVSAvoidskin permeability
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent implements a nested structure where cyclodextrin derivatives (outer layer) form inclusion complexes with active ingredients, and these complexes are then encapsulated within liposomes (inner layer). This nested arrangement allows cyclodextrins to provide solubility enhancement at the formulation level while liposomes provide the permeability enhancement at the skin delivery level, resolving the solubility-permeability trade-off.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The invention changes the physical-chemical parameters of the active ingredient delivery system by transitioning from direct application of poorly soluble compounds to a two-stage carrier system. The cyclodextrin derivation changes solubility parameters, while the liposome coating changes permeability parameters, allowing optimization of both concentration and skin penetration simultaneously.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition significantly improves the skin permeability of poorly soluble active ingredients, allowing for effective topical administration and delivery.

Implementation Method 1

wherein the active ingredient is associated with an alkylated or hydroxyalkylated derivative of β-cyclodextrin

Methodology Applied
Scientific EffectInclusion complex formation: Absorption (physical)

Implementation Method 2

improving the penetration of poorly soluble active ingredients into the skin

Methodology Applied
Scientific EffectPermeation: Permeation

Data Source

PatentEP4631497A1Liposomal composition for topical administration
Publication Date: 2025.10.15 EVANIUM HEALTHCARE GMBH
  • EP4631497A1 patent drawingFigure 1
  • EP4631497A1 patent drawingFigure 2
  • EP4631497A1 patent drawing

AI summary

The invention relates to a system of coated liposomes loaded with an active ingredient encapsulated in cyclodextrin. Furthermore, their use for improving the penetration of poorly soluble active ingredients into the skin and a method for producing the coated liposomes are described.